Zhongwen Zhou

1.3k total citations
39 papers, 1.0k citations indexed

About

Zhongwen Zhou is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Zhongwen Zhou has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Zhongwen Zhou's work include Pancreatic and Hepatic Oncology Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Zhongwen Zhou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Zhongwen Zhou collaborates with scholars based in China, Switzerland and United States. Zhongwen Zhou's co-authors include Peng Cui, Jing Zhao, Wenhong Zhang, Jing Wu, Guangjian Huang, Yunyun Qin, Lun–Xiu Qin, Cheng’en Hu, Peizhun Du and Ying Zhang and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Zhongwen Zhou

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongwen Zhou China 17 585 526 235 221 132 39 1.0k
Shaoying Lu China 14 414 0.7× 210 0.4× 184 0.8× 231 1.0× 167 1.3× 43 839
Seiji Naganuma Japan 16 429 0.7× 236 0.4× 242 1.0× 193 0.9× 116 0.9× 38 795
Sung‐Im Do South Korea 16 399 0.7× 258 0.5× 340 1.4× 145 0.7× 175 1.3× 84 913
Susheng Shi China 19 745 1.3× 627 1.2× 406 1.7× 190 0.9× 184 1.4× 49 1.2k
Rong-Zhen Luo China 20 737 1.3× 346 0.7× 274 1.2× 216 1.0× 230 1.7× 40 1.2k
Feng Tang China 16 436 0.7× 235 0.4× 314 1.3× 107 0.5× 121 0.9× 34 849
Mariusz Gryko Poland 16 209 0.4× 261 0.5× 419 1.8× 152 0.7× 114 0.9× 47 714
Masaru Shinozaki Japan 18 726 1.2× 344 0.7× 456 1.9× 170 0.8× 162 1.2× 45 1.3k
Weiwei Weng China 20 1.2k 2.0× 964 1.8× 362 1.5× 168 0.8× 241 1.8× 47 1.6k
Francesca Simionato Italy 17 290 0.5× 199 0.4× 455 1.9× 125 0.6× 199 1.5× 31 794

Countries citing papers authored by Zhongwen Zhou

Since Specialization
Citations

This map shows the geographic impact of Zhongwen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongwen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongwen Zhou more than expected).

Fields of papers citing papers by Zhongwen Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongwen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongwen Zhou. The network helps show where Zhongwen Zhou may publish in the future.

Co-authorship network of co-authors of Zhongwen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongwen Zhou. A scholar is included among the top collaborators of Zhongwen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongwen Zhou. Zhongwen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Yanyan, Lei Cao, Zhongwen Zhou, et al.. (2025). Head-to-head comparison of [18F]florbetapir and [18F]FDG PET for the early detection of amyloidosis in systemic amyloidosis and plasma cell dyscrasias. European Journal of Radiology. 189. 112188–112188. 1 indexed citations
2.
Kong, Yanyan, Fang Xie, Zhengwei Zhang, et al.. (2023). Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma. European Radiology. 33(10). 7077–7088. 6 indexed citations
3.
Yang, Feng, Wenchuan Wu, Xiaoyi Wang, et al.. (2020). Grading Solid Pseudopapillary Tumors of the Pancreas: the Fudan Prognostic Index. Annals of Surgical Oncology. 28(1). 550–559. 20 indexed citations
5.
Liu, Shenghua, Guanxiong Ding, Zhongwen Zhou, & Chenchen Feng. (2018). β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion. OncoTargets and Therapy. Volume 11. 2029–2036. 20 indexed citations
6.
Zhao, Jing, Peizhun Du, Peng Cui, et al.. (2018). LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene. 37(30). 4094–4109. 280 indexed citations
7.
Wang, Lujia, Chenchen Feng, Zhongwen Zhou, et al.. (2017). Tumor Wide Horizontal Invasion Predicts Local Recurrence for Scrotal Extramammary Paget’s Disease. Scientific Reports. 7(1). 44933–44933. 4 indexed citations
8.
Wang, Lujia, Chenchen Feng, Peng Gao, et al.. (2016). Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy. International Urology and Nephrology. 48(4). 495–501. 21 indexed citations
9.
Guo, Jingjing, Gang Wu, & Zhongwen Zhou. (2015). Polypoid lesions of the gallbladder: report of 160 cases with special reference to diagnosis and treatment in China.. PubMed. 8(9). 11569–78. 14 indexed citations
10.
Yu, Kangkang, et al.. (2015). Hepatic sarcoidosis mimicking liver cancer.. PubMed. 8(6). 9607–9. 1 indexed citations
11.
Wu, Gang, Jingjing Guo, Zhenyu Ma, et al.. (2015). Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.. PubMed. 8(2). 2010–7. 8 indexed citations
12.
Wang, Jie, et al.. (2013). Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: Improvement in the sensitivity or specificity?. Journal of International Medical Research. 41(4). 975–983. 25 indexed citations
13.
Li, Wenpeng, Wei Ding, Zhongwen Zhou, et al.. (2013). Abnormal hypermethylation and clinicopathological significance of FBLN1 gene in cutaneous melanoma. Tumor Biology. 35(1). 123–127. 10 indexed citations
14.
Yang, Feng, Chen Jin, Zunguo Du, et al.. (2013). Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes. The American Journal of Surgery. 206(3). 360–367. 33 indexed citations
15.
Wang, Lujia, Chenchen Feng, Guanxiong Ding, et al.. (2013). Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer. Tumor Biology. 35(4). 2989–2995. 32 indexed citations
16.
Feng, Chenchen, Lujia Wang, Zhongwen Zhou, et al.. (2012). Positive KI67 and Periodic Acid-Schiff Mandates Wider Range of Excision in Scrotal Extramammary Paget's Disease. Dermatologic Surgery. 39(3). 381–386. 4 indexed citations
17.
Fang, Yantian, Jianbin Xiang, Zongyou Chen, et al.. (2012). miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line. Oncology Reports. 28(6). 2115–2124. 26 indexed citations
18.
Li, Wenpeng, et al.. (2012). Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma. Tumor Biology. 34(2). 643–648. 19 indexed citations
19.
Li, Wenpeng, et al.. (2012). Serum soluble MICB (sMICB) correlates with disease progression and survival in melanoma patients. Tumor Biology. 34(1). 565–569. 8 indexed citations
20.
Zhou, Zhongwen. (2008). Experimental investigation of the effect of Lianhuaqingwen Capsule on the rat models of chronic obstructive pulmonary disease. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026